JPS5617359B2 - - Google Patents

Info

Publication number
JPS5617359B2
JPS5617359B2 JP8471072A JP8471072A JPS5617359B2 JP S5617359 B2 JPS5617359 B2 JP S5617359B2 JP 8471072 A JP8471072 A JP 8471072A JP 8471072 A JP8471072 A JP 8471072A JP S5617359 B2 JPS5617359 B2 JP S5617359B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8471072A
Other languages
Japanese (ja)
Other versions
JPS4832859A (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4832859A publication Critical patent/JPS4832859A/ja
Publication of JPS5617359B2 publication Critical patent/JPS5617359B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP8471072A 1971-08-26 1972-08-25 Expired JPS5617359B2 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7131032A FR2150254B1 (en:Method) 1971-08-26 1971-08-26

Publications (2)

Publication Number Publication Date
JPS4832859A JPS4832859A (en:Method) 1973-05-02
JPS5617359B2 true JPS5617359B2 (en:Method) 1981-04-22

Family

ID=9082246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8471072A Expired JPS5617359B2 (en:Method) 1971-08-26 1972-08-25

Country Status (16)

Country Link
US (1) US3790564A (en:Method)
JP (1) JPS5617359B2 (en:Method)
AU (1) AU471590B2 (en:Method)
BE (1) BE787898A (en:Method)
CA (2) CA974228A (en:Method)
CH (1) CH554855A (en:Method)
DD (1) DD99366A5 (en:Method)
DE (1) DE2241731C3 (en:Method)
DK (1) DK131189B (en:Method)
FR (1) FR2150254B1 (en:Method)
GB (2) GB1386440A (en:Method)
HU (1) HU163773B (en:Method)
IL (1) IL40022A (en:Method)
NL (1) NL176366C (en:Method)
SE (1) SE385709B (en:Method)
ZA (1) ZA725814B (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055562A (en) * 1975-10-06 1977-10-25 Sterling Drug Inc. Process for preparing pregn-20-yne compounds and novel product produced thereby
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
ZA725814B (en) 1973-10-31
GB1386439A (en) 1975-03-05
IL40022A0 (en) 1972-09-28
FR2150254B1 (en:Method) 1974-10-18
HU163773B (en:Method) 1973-10-27
NL176366B (nl) 1984-11-01
FR2150254A1 (en:Method) 1973-04-06
NL7211612A (en:Method) 1973-02-28
CH554855A (fr) 1974-10-15
US3790564A (en) 1974-02-05
BE787898A (fr) 1973-02-23
AU471590B2 (en) 1976-04-29
SU446965A3 (ru) 1974-10-15
DD99366A5 (en:Method) 1973-08-05
JPS4832859A (en:Method) 1973-05-02
IL40022A (en) 1975-10-15
CA974228A (en) 1975-09-09
CA996546A (fr) 1976-09-07
DE2241731A1 (de) 1973-03-08
AU4597372A (en) 1974-02-28
GB1386440A (en) 1975-03-05
SE385709B (sv) 1976-07-19
NL176366C (nl) 1985-04-01
DE2241731B2 (de) 1981-06-19
DE2241731C3 (de) 1982-05-06
DK131189C (en:Method) 1975-11-17
DK131189B (da) 1975-06-09

Similar Documents

Publication Publication Date Title
AU2658571A (en:Method)
FR2150254B1 (en:Method)
AU2691671A (en:Method)
AU2952271A (en:Method)
AU2564071A (en:Method)
AU2485671A (en:Method)
AU3005371A (en:Method)
AU2684071A (en:Method)
AU2941471A (en:Method)
AU2742671A (en:Method)
AU2706571A (en:Method)
AU2588771A (en:Method)
AU2654071A (en:Method)
AU2755871A (en:Method)
AU2684171A (en:Method)
AU2963771A (en:Method)
AU2577671A (en:Method)
AU2669471A (en:Method)
AU3025871A (en:Method)
AU2503871A (en:Method)
AU3038671A (en:Method)
AU2724971A (en:Method)
AU2456871A (en:Method)
AU2473671A (en:Method)
AU2486471A (en:Method)